Testing the Efficacy and Safety of the WEI Nasal Jet
Completed
- Conditions
- Complication of Surgical Procedure
- Interventions
- Device: Experimental group and control groupl
- Registration Number
- NCT02005406
- Lead Sponsor
- Zeyong Yang
- Brief Summary
Testing the efficacy and safety of the WEI Nasal Jet.
- Detailed Description
This is only initial thought and suggestions from the inventor Dr. Huafeng Wei. Principal investigator from each medical center interested in testing this new device should design their own clinical trials based on patient population and their own ideas for clinical trials. Just remind you that patient safety is number one and try all efforts to minimize patient risks during your clinical study.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 49
Inclusion Criteria
- Patients receiving various types of surgeries under sedation, especially for procedures of colonoscopy, upper gastrointestinal endoscopy, endoscopic retrograde cholangiopancreatography (ERCP) cystoscopy and other brief surgeries you are interested in the study.
Exclusion Criteria
- Patients with coagulopathy and tendency of nose bleeding.
- Patients with any diagnosed cardiac diseases (e.g. cardiac failure, angina, MI, cardiac arrhythmia. etc.)
- Patients with any diagnosed pulmonary disease (e.g. asthma, COPD, pulmonary embolism, pulmonary edema etc.)
- Pregnant patients
- Patients with liver failure
- Patients with kidney failure
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description wei group and control group Experimental group and control groupl wei group(n=25) and control group(n=24)
- Primary Outcome Measures
Name Time Method lowest SaO2 in Wei JET group 2 second Compare with Control group,there was no significant difference in lowest SaO2 in Wei JET group.
- Secondary Outcome Measures
Name Time Method